ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,859Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 1187

$1.01M Total Retail Price of All Prescriptions

Rank: 25 out of 1187

365 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 365 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 12,545 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 487 440 1 2
WARFARIN SODIUM 480 446 2 13
SIMVASTATIN 359 339 3 1
FUROSEMIDE 350 309 4 8
OMEPRAZOLE 344 314 5 5
FAMOTIDINE 329 320 6 48
NAMENDA 323 323 7 44
DONEPEZIL HCL 318 314 8 26
LEVOTHYROXINE SODIUM 274 250 9 3
JANUVIA 226 206 10 34
CARVEDILOL 219 210 11 19
METFORMIN HCL 208 160 12 7
DIVALPROEX SODIUM 184 182 13 79
SPIRIVA 171 155 14 55
ENALAPRIL MALEATE 168 149 15 27
METOPROLOL TARTRATE 160 141 16 10
CLOPIDOGREL 157 139 17 33
GABAPENTIN 156 129 18 23
LACTULOSE 153 153 19 96
ESCITALOPRAM OXALATE 153 124 19 51
ATORVASTATIN CALCIUM 153 129 19 6
EXELON 147 139 22 132
MIRTAZAPINE 135 127 23 54
TAMSULOSIN HCL 134 127 24 29
METOPROLOL SUCCINATE 128 118 25 11
POTASSIUM CHLORIDE 124 115 26 32
TRAMADOL HCL 122 121 27 28
LIDODERM 122 114 27 80
PLAVIX 121 111 29 52
NOVOLOG 116 116 30 135
DIOVAN 112 112 31 17
SINGULAIR 111 96 32 67
CLOTRIMAZOLE-BETAMETHASONE 108 89 33 100
DIGOXIN 108 102 33 65
GLIMEPIRIDE 105 85 35 30
LISINOPRIL 105 92 35 4
LANTUS 103 96 37 77
ALENDRONATE SODIUM 101 101 38 25
ALBUTEROL SULFATE 99 99 39 120
SPIRONOLACTONE 98 90 40 98
CARBIDOPA-LEVODOPA 95 95 41 99
FENTANYL 95 93 S2 41 82
PANTOPRAZOLE SODIUM 94 82 43 42
ISOSORBIDE MONONITRATE ER 94 87 43 66
ADVAIR DISKUS 85 61 45 35
NEXIUM 85 63 45 15
JANUMET 85 79 45 111
SERTRALINE HCL 84 78 48 22
HYDROCHLOROTHIAZIDE 83 74 49 9
LOVAZA 79 65 50 53
LOSARTAN POTASSIUM 77 68 51 21
RAMIPRIL 76 72 52 36
MELOXICAM 74 68 53 49
RISPERIDONE 72 61 54 58
LEVETIRACETAM 72 72 54 89
PREDNISONE 72 67 54 61
MUPIROCIN 71 64 57 127
MEGESTROL ACETATE 70 70 R 58 185
FLUTICASONE PROPIONATE 66 60 59 31
CLONIDINE HCL 66 62 59 73
MONTELUKAST SODIUM 66 55 59 129
AMIODARONE HCL 66 60 59 205
ALLOPURINOL 62 61 63 50
NAPROXEN 60 57 64 72
NOVOLIN R 60 54 64 372
PATADAY 60 57 64 215
ATENOLOL 58 58 67 18
POLYETHYLENE GLYCOL 3350 57 46 68 86
OXYCODONE-ACETAMINOPHEN 57 51 S2 68 47
RENVELA 56 56 70 380
HYDROCODONE-ACETAMINOPHEN 56 38 S3 70 20
SANTYL 55 55 72 150
QUETIAPINE FUMARATE 54 54 73 75
LEXAPRO 53 45 74 258
ZOLPIDEM TARTRATE 53 39 74 14
NITROGLYCERIN PATCH 52 48 76 138
PRANDIN 52 52 76 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.